AXSM Operating Income Growth
Axsome Therapeutics Inc · Operating Income Growth
AXSM Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported17.64%period ending
AXSM TTM Operating Income YoY % (-67.57% → 17.64%)
Year-over-year change
High-resolution chart · PNG
AXSM operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 17.6446% | |
| 35.024% | |
| 39.68% | |
| 30.6307% | |
| 25.1142% | |
| 7.6717% | |
| -21.0232% | |
| -58.2789% | |
| -75.941% | |
| -97.943% | |
| -28.9357% | |
| -26.8725% | |
| -21.0996% | |
| -9.4206% | |
| -44.1772% | |
| -27.2414% | |
| -33.3967% | |
| -43.027% | |
| -25.787% | |
| -25.0642% | |
| -14.8614% | |
| -5.7984% | |
| -47.4328% | |
| -83.3371% | |
| -125.3077% | |
| -147.377% | |
| -104.7248% | |
| -75.1561% | |
| -49.0032% | |
| -35.45% | |
| -20.9181% | |
| -5.2729% | |
| 4.6547% | |
| 9.127% | |
| 1.3767% | |
| -22.8552% | |
| -63.5472% | |
| -123.1297% | |
| -199.5072% | |
| -188.7631% | |
| -133.4391% | |
| -102.2583% | |
| -67.574% |